CAMBRIDGE, Mass., May 07, 2019 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today reported financial results for the first quarter ended March 31, 2019, and recent business highlights.First Quarter 2019 Financial Highlights Total net product revenues increased 21% to $21.8 million …